MetaCap

Tactile Systems Technology (TCMD) vs vVARDIS (VVVV)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

vVARDIS is the larger company by market cap ($770.9 million vs $573.5 million), about 1.3 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

TCMD-4.51%VVVV-11.82%
+1%-6%-12%
Nov 13, 20261 yearNov 20, 2026
TCMD-4.51%VVVV-11.82%
+1%-6%-12%
Nov 9, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

TCMD versus VVVV key metrics
MetricTCMDVVVV
Share price$25.60$14.55
Market cap$573.48M$770.91M
1-day change-1.50%-3.00%
YTD return-11.72%—
1-year return-0.39%—
5-year return+23.85%—
P/E ratio (TTM)24.85—
Forward P/E17.41—
EPS (TTM)$1.03$-0.29
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$329.52M—
Revenue growth (YoY)+12.47%—
Net income (latest FY)$19.09M—
Gross margin75.91%—
Operating margin8.89%—
Net margin5.79%—
52-week high$37.77$16.95
52-week low$20.53$14.00
Distance from 52-week high-32.22%-14.16%
Analyst consensusstrong_buy—
Avg. price target upside+41.91%—
Average volume248.63K963.08K
Shares outstanding22.40M38.59M
Employees1,086153
SectorHealth CareHealth Care
IndustryMedical/Dental InstrumentsMedical/Dental Instruments

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Tactile Systems Technology

TCMD stock →

Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds.

Health Care · Medical/Dental Instruments · 1,086 employees

About vVARDIS

VVVV stock →

vVARDIS Holding AG, a dental medtech company, develops and provides non-invasive cavity treatment products in Switzerland and the United States. The company offers the Curodont platform, including Curodont Repair, a biomimetic system to arrest and reverse early caries through enamel regeneration; Curodont Protect, a remineralising tooth gel containing the biomimetic Oligo-Peptide 103 technology; and Enamel Serum, enriched with peptides and hydroxyapatite, which delivers calcium and phosphate ions to care for the enamel.

Health Care · Medical/Dental Instruments · 153 employees

TCMD vs VVVV FAQ

Which is bigger, Tactile Systems Technology or vVARDIS?

vVARDIS (VVVV) is larger, with a market capitalization of $770.91M compared with $573.48M for Tactile Systems Technology (TCMD).

Are Tactile Systems Technology and vVARDIS in the same industry?

Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.

More comparisons